Intrathecal immunoglobulin for treatment of adult patients with tetanus: A randomized controlled 2x2 factorial trial

<p>Despite long-standing availability of an effective vaccine, tetanus remains a significant problem in many countries. Outcome depends on access to mechanical ventilation and intensive care facilities and in settings where these are limited, mortality remains high. Administration of tetanus a...

Täydet tiedot

Bibliografiset tiedot
Päätekijät:	Loan, H, Yen, L, Kestelyn, E, Hao, N, Thanh, T, Dung, N, Turner, H, Geskus, R, Wolbers, M, Tan, L, Van Doorn, H, Day, N, Wyncoll, D, Hien, T, Thwaites, G, Vinh Chau, N, Thwaites, C
Aineistotyyppi:	Journal article
Julkaistu:	F1000Research 2018

Intrathecal Immunoglobulin for treatment of adult patients with tetanus: A randomized controlled 2x2 factorial trial Tekijä Loan, H, Yen, L, Kestelyn, E, Hao, N, Thanh, T, Dung, N, Turner, H, Geskus, R, Wolbers, M, Tan, L, Van Doorn, H, Day, N, Wyncoll, D, Hien, T, Thwaites, G, Vinh Chau, N, Thwaites, C

Julkaistu 2018

Journal article

Intrathecal immunoglobulin for treatment of adult patients with tetanus: A randomized controlled 2x2 factorial trial

Samankaltaisia teoksia